Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Best Practice & Research. Clinical Endocrinology & Metabolism|November 26, 2008
Health economics of osteoporosisFredrik Borgström, John A Kanis
Cost Effectiveness and Resource Allocation : C/E|August 20, 2015
Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in SwedenOskar Eklund, Faraz Afzal, Fredrik Borgström
Advances in Therapy|October 19, 2019
A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT® Re-usable in the Nordics and BeneluxGustaf Ortsäter, Fredrik Borgström, Stéphane Soulard, et al.
International Journal of Technology Assessment in Health Care|November 3, 2005
Reassessment of the cost-effectiveness of hormone replacement therapy in Sweden: results based on the Women's Health Initiative randomized controlled trialNiklas Zethraeus, Fredrik Borgström, Bengt Jönsson, et al.
Bone|April 17, 2007
The societal burden of osteoporosis in SwedenFredrik Borgström, Patrik Sobocki, Oskar Ström, et al.
Applied Health Economics and Health Policy|December 7, 2019
Incorporating the Environmental Impact into a Budget Impact Analysis: The Example of Adopting RESPIMAT® Re-usable InhalerGustaf Ortsäter, Fredrik Borgström, Mike Baldwin, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|August 30, 2018
Cost of low back pain: results from a national register study in SwedenGylfi Olafsson, Emma Jonsson, Peter Fritzell, et al.
Pageof 6